Werbung
Werbung
FULC
Fulcrum Therapeutics, Inc. Common Stock
9.85
USDGesponsert
-0.26
-2.56%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
9.91
+0.06
+0.60%
FULC Ergebnisberichte
Positives Überraschungsverhältnis
FULC übertreffen die 19 der letzten 26Schätzungen.
73%
Nächster Bericht
Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.31
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/--
Fulcrum Therapeutics, Inc. Common Stock earnings per share and revenue
On 29. Okt. 2025, FULC reported earnings of -0.31 USD per share (EPS) for Q3 25, missing the estimate of -0.29 USD, resulting in a -3.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Fulcrum Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fulcrum Therapeutics, Inc. Common Stock reported EPS of -$0.31, missing estimates by -3.47%, and revenue of $0.00, 0% as expectations.
How did the market react to Fulcrum Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -6.4%, changed from $10.00 before the earnings release to $9.36 the day after.
When is Fulcrum Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23. Feb. 2026.
What are the forecasts for Fulcrum Therapeutics, Inc. Common Stock's next earnings report?
Based on 12
analysts, Fulcrum Therapeutics, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung